Scope History (select icon to view/hide Scope History)
|
Action Type |
ASCA Status |
Effective Start Date
|
Biocompatibility Test Method
|
Recognition Number
|
Designation Number |
Exclusions |
| Accredit |
Accreditation Granted |
08/06/2026 |
|
19-50
|
TS 60601-4-2 Edition 1.0 2024-03
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
19-46
|
ES60601-1:2005/(R)2012 & A1:2012, C1:2009/(R)2012 & A2:2010/(R)2012 (Cons. Text) [Incl. AMD2:2021]
|
Excluding clauses 8.5.5, 8.5.5.2, 8.8.4.2, 9.6.2.1, 9.6.3, 10.1.1, 11.2.2.1, 11.6.7, 15.4.3
NOTE: Exclusions listed for ANSI AAMI ES60601-1 also apply to other collaterals and particulars in the 60601/80601 family of standards except where otherwise stated.
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
19-34
|
61010-1 Edition 3.1 2017-01 CONSOLIDATED VERSION
|
Excluding clauses 12.2.1, 12.5.1, 12.5.2
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
19-36
|
60601-1-2 Edition 4.1 2020-09 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
19-4
|
ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012 (Consolidated Text)
|
Excluding subclauses 8.5.5, 8.5.5.2, 8.8.4.2, 9.6.2.1, 9.6.3, 10.1.1, 11.2.2.1, 11.6.7, 15.4.3
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
19-8
|
60601-1-2 Edition 4.0 2014-02
|
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
5-132
|
60601-1-6 Edition 3.2 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
03/07/2022 |
|
5-89
|
60601-1-6 Edition 3.1 2013-10
|
|
|